Skip to content

Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Sep 3, 2015
SAN DIEGO, Sept. 3, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview and update at the Wells Fargo 2015 Healthcare Conference on Wednesday, September 9, 2015, at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time), at the Hyatt Regency in Boston, Massachusetts...
Aug 5, 2015
SAN DIEGO, Aug. 5, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today reported financial results for the second quarter ended June 30, 2015, and provided a corporate update. "We have continued to advance our deep clinical-stage pipeline, as evidenced by the recent initiation of a Phase 2 proof-of-concept clinical trial of ...
Jul 30, 2015
SAN DIEGO, July 30, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that it will host a conference call and webcast at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) on Wednesday, August 5, 2015, to discuss second quarter 2015 financial results and provide a corporate update. Arena will release its financial results...
Jul 29, 2015
SAN DIEGO, July 29, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today the initiation of patient screening in a Phase 2 proof-of-concept clinical trial of APD334 in ulcerative colitis. Discovered by Arena, APD334 is an oral, investigational, Sphingosine 1-Phosphate Subtype 1 (S1P1) receptor modulator with therapeutic po...
Jun 16, 2015
SAN DIEGO, June 16, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that Robert E. Hoffman, Senior Vice President, Finance and Chief Financial Officer, has decided to leave the company after nearly 18 years of service to pursue another opportunity in the biotechnology industry. Mr. Hoffman is expected to remain in hi...
Jun 4, 2015
WOODCLIFF LAKE, N.J. and SAN DIEGO, June 4, 2015 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the following poster regarding lorcaserin HCl will be presented at American Diabetes Association's 75th Scientific Sessions taking place June 5-9, 2015, in Boston, Massachusetts: Impact of ...
May 26, 2015
SAN DIEGO, May 26, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview and update at the Jefferies 2015 Global Healthcare Conference on Monday, June 1, 2015, at 10:30 a.m. Eastern Time (7:30 a.m. Pacific Time), at the Grand Hyatt in New York, New York. ...
May 14, 2015
WOODCLIFF LAKE, N.J., and SAN DIEGO, May 14, 2015 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that lorcaserin HCl data will be presented at the following medical meetings: American Thoracic Society International Conference taking place in Denver, Colorado, May 15-20, 2015Lorcaserin for Smokin...
May 11, 2015
SAN DIEGO, May 11, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today provided a corporate update and reported financial results for the first quarter ended March 31, 2015. "We are pleased with the progress we have made thus far in 2015, including the approval and launch of BELVIQ in South Korea, our entry into a collabora...
May 11, 2015
SAN DIEGO, May 11, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that its subsidiary, Arena Pharmaceuticals GmbH, and Roivant Sciences Ltd., have entered into a Development, Marketing and Supply Agreement for nelotanserin, Arena's internally discovered inverse agonist of the 5-HT2A receptor. The agreement grants Ro...
May 8, 2015
SAN DIEGO, May 8, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview and update at the Bank of America Merrill Lynch 2015 Health Care Conference on Wednesday, May 13, 2015, at 9:20 a.m. Pacific Time (12:20 p.m. Eastern Time), at the Encore at the Wynn in Las ...
May 7, 2015
SAN DIEGO, May 7, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that it will host a conference call and webcast at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) on Monday, May 11, 2015, to provide a corporate update and discuss first quarter 2015 financial results. Arena will release its financial results after t...
Apr 29, 2015
SAN DIEGO, April 29, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced favorable results from a Phase 1 single-ascending dose clinical trial of APD371, a highly selective and potent agonist of the cannabinoid 2 (CB2) receptor currently in development for the treatment of pain and potentially fibrotic diseases. T...
Apr 10, 2015
WOODCLIFF LAKE, N.J. and SAN DIEGO, Calif., April 10, 2015 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced the completion of two Phase 1 registrational clinical trials that Eisai and Arena believe demonstrate bioequivalence of an investigational once-daily extended release formulation of lorcaserin, as comp...
Apr 9, 2015
SAN DIEGO, April 9, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview and update at the 14th Annual Needham Healthcare Conference on Wednesday, April 15, 2015, at 12:50 p.m. Eastern Time (9:50 a.m. Pacific Time), at the Westin Grand Central Hotel in New York...
Page: First Previous
...
...
Next Last
 
= add release to Briefcase